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1. Abstract 
As per the literature, bioactive compounds isolated or purified from medicinal plant products that are generally 
used for curing various human diseases. The present study involves two different medicinal plants i.e. Aegle 
marmelosand Emblica officinalis were locally available in Baramati region of Maharashtra, India. The leaves of 
these medicinal plants were used for phytochemical analysis in aqueous extract using phosphate buffered 
saline (PBS; pH 7.2) in order to find out the active metabolites using liquid chromatography mass 
spectrometry (LC-MS). For these studies, aqueous leaves extract of these two medicinally plants were tested 
for immunological studies in mice model studies especially Swiss mice pertaining to determine splenocyte 
proliferation assay using hepatitis B vaccine containing surface antigen (HBsAg) and also determined pro-
inflammatory cytokines (IFN-gamma and TNF alpha) by Elisa. The results showed that aqueous leaves 
extract showed declined in splenocyte proliferation assay and proinflammatory cytokines (FN-gamma and 
TNF alpha) at higher doses as compared to control samples. HBsAg (20 µg/ml) used as standard for these 
studies. Overall, the results showed that aqueous leaves extract of Aegle marmelosand Emblica officinalis 
showed immunosuppressive activity against HBsAg as compared to control. 
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2. Introduction  
India has a rich history of using various medicinal plant products for treating various diseases. Most of the medicinal 
plants are investigated or reported for its beneficial use against different types of diseases and reported as well as 
published in numerous scientific journals [1, 2]. In other words, use of medicinal plant products as a source of medicine 
against human diseases and showed its importance in human health care system in India [3]. Currently, most of the 
medicinal plants are recommended for various diseases having no side effects. As per Indian traditional system, these 
medicinal plants are continuously used for therapy related to cardiovascular disease and inflammation [4, 5].Several 
medications that are available to suppress over-reactive T lymphocytes, but many of the currently marketed drugs 
produce severe and life-threatening side-effects [6]. The most commonly used immunosuppressive drugs especially 
Cyclophosphamide, betamethasone etc. and historically one of the oldest are the glucocorticoids [6, 7]. These 
immunosuppressive drugs are generally restricted and inhibited the synthesis and secretion of inflammatory cytokines 
and support the activation of anti-inflammatory signalling cascades. In addition, these immunosuppressive drugs showed 
various side effects including toxic effect as well [6, 7]. However, many of immunosuppressive drugs cause unwanted 
and severe side-effects in patients and therefore there is a high demand for medicinal plant products that showed less-
toxic immunosuppressive pharmaceuticals [8, 9]. 
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One of the medicinal plants i.e. Aegle marmelos (Bael; family Rutaceae) and Emblica officinalis (Amla; family 
Euphorbiaceae) showed various immunopharmacological properties i.e. anti-inflammatory, anti-oxidant, antidiabetic, 
antimicrobial, proteases etc. [10-12].In view of this, we focused on various medicinal plant products especially aqueous 
leaves extract of Aegle marmelos and Emblica officinalis in order to determine its immunosuppressive effect against 
HBsAg. 
3. Methodology 
3.1. Plants Material 
Fresh plant leaves of Aegle marmelos and Emblica officinalis were collected in January 2016 from Baramati region, 
Maharashtra, India. These medicinal plants were identified by Late Dr Sharadini Dahanukar (founder of Nakshatra 
udyan, Vidya Pratishthan’s) for mentioning the importance and medicinal use of medicinal plant especiallyAegle 
marmelos and Emblica officinalis in Marathi book language (Nakshatra vriksha). 
3.2. Preparation of Aqueous Extracts 
Five grams (5 g) of powdered plant material of Aegle marmelos and Emblica officinalis were extracted or macerated 
with phosphate buffered saline (PBS, 50 mL) using mortar and pestle.  
During filtration, extract residues were removed and collect the supernatant for the estimation of secondary metabolites 
in the aqueous leaves extract. 
3.3. LC-MS Analysis 
Aqueous extract of Aegle marmelos and Emblica officinalis (Fig.1) were subjected to LC-MS (LC:  Agilent 1260 binary 
LC System; Column:  Agilent Zorbax SB 18 RRHT column, 100×2.1 mm, 1.8µm); Flow rate:  0.3mL/min; Run time: 30 
min; Injection Vol:  1μL and MS: 6540 ultra-high definition accurate mass QTOF LC/MS system; Mobile phase A: 
Water, 0.1% Formic acid; Mobile phase B: Acetonitrile) analysis and compounds were distinguished based on their mass 
spectra, using precursorand fragment ions as well as comparison of the fragmentation patterns with molecules described 
in the molecular database. All mass spectrometric (MS) acquisitions were performed in the 
positive electrospray ionization modewhereas capillary, cone and fragment or voltage were recorded at different set 
points i.e. 4 kV, 45V and 170V, respectively. The gas temperature was set at 325 ºC. Data was acquired at scan rate of 
3Hz in mass range 100-100 m/z. Further data was analysed with Mass hunter qualitative software and METLIN 
database.  
A) Aegle marmelos 
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B) Emblica officinalis 
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Fig.1. MS spectra for representative bioactive phytochemicals identified in Aegle marmelos and Emblica 
officinalis. 
3.4. Animals Handling 
Swiss mice (22-26 g; female) were used for this study. All animals were kept in preclinical research centre, VSBT 
Baramati under controlled conditions of 12-h light/and 12 h without light and 25°C. Experiments on these animals 
especially Swiss mice were performed according to the protocols already approved by Animal ethics committee and met 
the international standards for animal study. 
3.5. Splenocyte Proliferation Assay 
Splenocytes were collected by careful dissection from the abdominal cavity of mouse and then prepared single cell 
suspension(using froster slides) and then passed through cell strainer (70 µm) pertaining to remove cell debris.  
For these studies, spleen cells were cultured at 2 × 10
6
 cells/ml, 100 µl in RPMI 1640 medium containing 10% heat-
inactivated Fetal calf serum (FCS) along with penicillin (100 IU/ml) and streptomycin (100 μg/ml) in 96 well tissue 
culture plate. Spleen cells were cultured with HBsAg (2 μg/ml) along with serial dilution of aqueous leaves extract of 
Aegle marmelos and Emblica officinalis (62.5 – 500 µg, 50 µl) for 48 h incubation. Afterwards, splenocyte culture 
supernatant was collected for the estimation of Th1 cytokines and were stored at −70°C until analysis of cytokine 
concentrations by ELISA. Afterwards, add fresh medium in 96 well plate and then add MTT (2.5 mg/ml; 10 µl) solution. 
Incubate the plate for another 4 h at carbon dioxide incubator. After incubation, centrifuge the plate and observed 
formazon crystals settled at the bottom and then discard the supernatant. Dissolve the formazon crystals in dimethyl 
sulphoxide (DMSO) solution and then analyzed its optical density (OD) at 570 nm [13, 14]. 
3.6. Estimation of Th1 Cytokines by ELISA 
Th1 (IFN-gamma and TNF alpha) cytokine concentrations in the splenocyte cell culture supernatant were determined by 
ELISA (BD optia kit). This study was performed according to the manufacturer's instructions [13, 14]. 
3.7. Statistical Analysis 
The difference between controls, standard and aqueous leaves extract of Aegle marmelos and Emblica officinalis is 
determined by one way ANOVA test (Boniferroni multiple comparison test). 
 
4. Results 
4.1. Splenocyte Proliferation Assay 
The effect of aqueous leaves extract of Aegle marmelos and Emblica officinalis on splenocyte proliferation assay 
containing HBsAg as shown in Fig.2. The results showed that aqueous leaves extract showed reduction in HBsAg 
proliferation at higher doses as compared to control. 
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Fig.2. Effect of variable doses of aqueous leaves extract on splenocyte proliferation assay in mice model studies. 
Spleen cells (10
6
 cells/ml; 100 µl) were treated with variable doses of aqueous leaves extract of Aegle marmelos and 
Emblica officinalis (62.5 – 500 µg, 50 µl) in presence HBsAg (as already described in materials and methods section). 
Values are expressed in Mean ± S.E. The difference between the control, standard and aqueous leaves extract is 
determined by one way ANOVA test. *P<0.05, **P <0.01 and ***P< 0.001 
4.2. Th1 Cytokines 
The effect of aqueous leaves extract of Aegle marmelos and Emblica officinalis on Th1 (IFN-gamma and TNF alpha) 
cytokines from splenocyte cell culture supernatant containing HBsAg as shown in Fig.3. The results showed that aqueous 
leaves extract showed inhibition in Th1 cytokines at higher doses as compared to control. 
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Fig.3. Effect of variable doses of aqueous leaves extract on Th1 cytokines from splenocyte cell culture supernatant. 
Spleen cells (10
6
 cells/ml; 100 µl) were treated with variable doses of aqueous leaves extract in presence HBsAg and cell 
culture supernatant was collected for the estimation of cytokines (IFN-gamma and TNF alpha). Values are expressed in 
Mean ± S.E. The difference between the control, standard and aqueous leaves extract is determined by one way ANOVA 
test. *P<0.05, **P <0.01 and ***P< 0.001 
5. Discussion 
Medicinal plants especially Aegle marmelos and Emblica officinalis has been shown to possess many important 
medicinal benefits including anti-inflammatory, anti-oxidant, anti-bacterial, and anti-fungal activities [10-12]. Plant 
metabolites in the form of aqueous leaves extract that mediate these immunological effects and their mechanism of action 
are poorly understood. In order to achieve this objective, we focused on active metabolites that are present in aqueous 
leaves extract that are responsible for immunosuppressive activity. During phytochemical investigation using LC-MS, 
number of phytoconstitutents are identified (based on the mass to charge ratio ofrespective phytoconstituent) inAegle 
marmelosand showed various bioactive molecules such as Noscapin at retention time (rt) 9.78-9.96 min and [M+H]
 +
 ion 
at m/z 436. Noscapin is an Opioid alkaloid, used as an antitussive agent and a tubulin-binding antitumor agent. Embelin 
is well known anti-tumor agent having wound healing property and anti-proliferative activities [15-18]. Embelin having 
rt 10.34-10.67 min and shows prominent peak of [M+H]
+
 ion at m/z 277. LC-MS could identify α-Erythroidine at rt 
10.41-10.75 min showing [M+H]
+
 ion at m/z 256. Amorolfine is showing activity against fungal nail infections, eluted at 
rt 10.80-10.98 min, [M+H] 
+
 ion at m/z 335. 
Similarly, active phyto-molecules were identified from the aqueous extract of Emblica officinalis are Granisetron, a 5-
hydroxytryptamine 3 (5-HT(3))-receptor antagonist indicated for the prevention of nausea and/or vomiting[19] shows rt 
13.98-14.16 min [M+H]
+
 ion at m/z 295. Punctaporin B with rt 16.28-16-45 min and [M+H]
 +
 ion at m/z 235, which is 
reported for antitumor activity [19]. Nanoxynol is widely used in contraceptives for its spermicidal properties. It was 
eluted at rt 17.81-17.93 min with [M+H]
+
 ion at m/z 634. Cloprostenol used as a luteolytic agent which causes functional 
and morphological regression of the corpus luteum followed by return to oestrus and normal ovulation in cattle. It may 
also be used for the induction of parturition in pregnant cows, sows and mares showing rt 19.04-19.10 min and [M+H]
+
 
ion at m/z 223. 
In India, numerous varieties of medicinal plants weregrown because of climatic and geographical variations. More than 
1000 medicinal plant species were recorded and showed various immunopharmacological properties. As per the 
literature, different species of medicinal plants such as Azadirachta indica, Ficus racemosa, Syzygiumcumini, Ficus 
benghalensisetc. [20-23] have been shown to have appreciable anti-inflammatory and immunosuppressive activity. 
Modulation of immune cell responseusing medicinal plant products may lead to discovery of new drugs for human 
against various infectious diseases. In this study, we aimed to evaluate splenocyte proliferation assay using HBsAg and 
determined Th1 cytokines from cell culture supernatant. The results showed that aqueous leaves extract showed 
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markedly decline in HBsAg proliferation and Th1 (IFN-gamma and TNF alpha) cytokines at higher doses as compared to 
control. Overall, the data showed that these medicinal plants especially Aegle marmelos and Emblica officinalis showed 
immunosuppressive effect. 
Cytokines played an important role in the pathogenesis of various immunological disorders especially Th1 type of 
cytokines i.e. IFN-gamma and TNF alpha, has been the subject of intense investigation in the past few years [13,14]. 
Recently, animal models provide the most advanced tool available for analysing the relationship between cytokines and 
immunological disorders. In this study, we determined as well as evaluated the expression of proinflammatory cytokines 
(IFN-gamma and TNF alpha) against HBsAg and somewhat unexpectedly, these models have also revealed that cytokine 
factors can act both as potentiating and inhibitory agents, depending upon the site and timing of exposure. Cytokinesi.e. 
IFN-gamma and TNF alpha are well known to play an important roles for eliminating various viral infections or 
intracellular pathogens [13, 14]. In this study, we found significant decrease in IFN-gamma and TNF alpha productionin 
splenocyte cell culture supernatant and also suppressed HBsAg-mediated proliferation at higher doses in splenocytes. 
Overall, this data indicated that proinflammatory mediators serve as a biomarker for immunosuppressive activity against 
specific protein antigen. These observations indicated that aqueous leaves extract of these two medicinal plants have 
potential effects in downregulating the immune system and might be developed as a better and useful 
immunosuppressive agent in treating undesired immune responses. 
6. Conclusion 
The results of aqueous leaves extract of these two medicinal plants clearly indicates its immunosuppressive effectagainst 
HBsAgi.e. decline in splenocyte proliferation and Th1 (IFN-gamma and TNF alpha) cytokines production. Overall 
studies showed that immunosuppressive activity of Aegle marmelos and Emblica officinalis could be because of 
bioactive phytoconstituents present in aqueous extract which were identified through LC-MS.  
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